DRRX

DRRX

USD

DURECT Corporation Common Stock

$0.670-0.040 (-5.690%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$0.710

Kõrge

$0.720

Madal

$0.632

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

21.7M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

0.05M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.63Praegune $0.670Kõrge $1.88

Seotud uudised

Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Durectto Neutral

HC Wainwright & Co. analyst Ed Arce reiterates Durect from Neutral to Neutral.

Vaata rohkem
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
PR Newswire

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided a...

Vaata rohkem
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PR Newswire

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated ...

Vaata rohkem
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update